BRIEF published on 03/31/2026 at 13:12, 5 months 6 days ago Poxel vend le PXL770 à Scynexis pour un montant pouvant atteindre 196 millions de dollars Biopharmaceutique Poxel PXL770 SCYNEXIS ADPKD
BRIEF published on 03/31/2026 at 13:12, 5 months 6 days ago Poxel cède le PXL770 à Scynexis pour une valeur potentielle de 196 millions de dollars Accord Financier Poxel PXL770 SCYNEXIS Polykystose Rénale
PRESS RELEASE published on 03/31/2026 at 13:07, 5 months 6 days ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Poxel annonce la cession du PXL770 à Scynexis pour jusqu'à 196 millions de dollars, renforçant sa position financière. Étude clinique phase 2 prévue pour ADPKD. Accord financier détaillé Cession Accord Financier Poxel PXL770 SCYNEXIS
PRESS RELEASE published on 03/31/2026 at 13:07, 5 months 6 days ago Inside Information / Operations of the issuer (acquisitions, sales...) Poxel announces sale of PXL770 for up to $196 million to SCYNEXIS. PXL770 targets ADPKD. Agreement includes upfront payment, development and commercial milestones. Phase 2 study planned for Q4 2026 Milestones Poxel PXL770 SCYNEXIS ADPKD
BRIEF published on 03/25/2026 at 22:03, 5 months 12 days ago Poxel obtient un financement supplémentaire grâce à de nouvelles obligations PDR de tranche D Financement Poxel Tranche D PDR Partenaires De L'IPF Plan De Continuité
BRIEF published on 03/25/2026 at 22:03, 5 months 12 days ago Poxel Secures Additional Financing Through New Tranche D PDR Bonds Financing Continuation Plan Poxel IPF Partners Tranche D PDR
PRESS RELEASE published on 03/25/2026 at 21:58, 5 months 12 days ago Inside Information / News release on accounts, results Poxel confirms drawdown under Tranche D PDR bond issue for €3.75 million with IPF as part of continuation plan validated by Lyon Commercial Court. Key details and financing prospects outlined Financing Opportunities Poxel IPF Partners Tranche D PDR
PRESS RELEASE published on 03/25/2026 at 21:58, 5 months 12 days ago Informations privilégiées / Communiqué sur comptes, résultats Poxel confirme la mise à disposition de l’emprunt obligataire complémentaire Tranche D PDR dans le cadre du plan de continuation. Analyse des termes de la Tranche D PDR et sécurisation du financement Financement Emprunt Obligataire Plan De Continuation Poxel Tranche D PDR
BRIEF published on 02/03/2026 at 08:45, 7 months 3 days ago Poxel établit une ligne de crédit en fonds propres avec IRIS Capital Financement Poxel IRIS Capital Plan De Rétablissement Ligne De Crédit Sur Fonds Propres
BRIEF published on 02/03/2026 at 08:45, 7 months 3 days ago Poxel Establishes Equity Line with IRIS Capital Financing Recovery Plan Equity Line Poxel IRIS Capital
Published on 09/05/2026 at 04:05, 2 days 4 hours ago Pelican AI Corp. Announces Proposed Share Issuances and Litigation Update
Published on 09/04/2026 at 23:30, 2 days 8 hours ago FutureGen Industries Announces Shares for Debt Settlement
Published on 09/04/2026 at 23:00, 2 days 9 hours ago Golden Minerals Announces Management Change and Argentine Project Update
Published on 09/04/2026 at 22:30, 2 days 9 hours ago Panther Minerals Closes Brokered Private Placement of $3,000,000
Published on 09/04/2026 at 14:30, 2 days 17 hours ago Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF)
Published on 09/07/2026 at 08:00, 15 minutes ago £175m first close of Molten Ventures Growth Fund with cornerstone commitment from British Business Bank
Published on 09/07/2026 at 07:30, 45 minutes ago Hannover Re sees profitable growth opportunities in an increasingly challenging market environment
Published on 09/07/2026 at 07:00, 1 hour 15 minutes ago Swiss Re sees growing protection needs as risks become more complex and interconnected
Published on 09/07/2026 at 07:00, 1 hour 15 minutes ago Half-year results for 2026 show a further increase
Published on 09/04/2026 at 18:57, 2 days 13 hours ago Disclosure of transactions in own shares from September 1 to September 4, 2026
Published on 09/04/2026 at 18:57, 2 days 13 hours ago Déclaration hebdomadaire d'opérations effectuées du 1er au 4 septembre 2026
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/04/2026 at 18:15, 2 days 14 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES AOÛT 2026
